HOUSTON--(BUSINESS WIRE)--Insperity, Inc. (NYSE: NSP), a leading provider of human resources and business performance solutions for America's best businesses, today announced that its board of directors has declared a quarterly cash dividend of $0.60 per share. The cash dividend will be paid on December 23, 2025, to all stockholders of record as of December 9, 2025. About Insperity Since 1986, Insperity's mission has been to help businesses succeed so communities prosper. Offering a suite of th.

DENVER--(BUSINESS WIRE)--Royal Gold to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series on Thursday, December 4, 2025.

The Chairman of the world's second-largest lithium processor made bullish comments on lithium prices for 2026. A sell-side analyst upped his price target on Sigma Lithium's shares two days later.

BJ's Wholesale Club (BJ) came out with quarterly earnings of $1.16 per share, beating the Zacks Consensus Estimate of $1.1 per share. This compares to earnings of $1.18 per share a year ago.

AI stocks are getting a lot of hype right now. But history shows that revolutionary technologies almost always become overvalued and overinvested, leading to eventual corrections. Disciplined, long-term investing - resisting FOMO and sticking to a well-designed plan -remains the best path to enduring wealth.

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

Shares of AnaptysBio fell 14% in premarket trading on Friday after the U.S. drug developer and Tesaro, a unit of Britain's GSK , filed lawsuits against each other, with both claiming a breach in a partnership deal for a cancer drug.

NVIDIA delivered a blockbuster third-quarter earnings report yesterday, surpassing Wall Street expectations with record revenue of $57 billion and providing an upbeat forecast that contrasts concerns about an AI bubble, according to CNBC. CEO Jensen Huang highlighted robust demand for the company's AI chips, stating NVIDIA has visibility into a half-trillion-dollar sales pipeline for 2025 and 2026, excluding recent major deals like expansions with Anthropic and Saudi Arabia.

ZIM Integrated Shipping Services Ltd. ( ZIM ) Q3 2025 Earnings Call November 20, 2025 8:00 AM EST Company Participants Elana Holzman - Head of Investor Relations Eliyahu Glickman - President & CEO Xavier Destriau - Executive VP & CFO Conference Call Participants Omar Nokta - Jefferies LLC, Research Division Marco Limite - Barclays Bank PLC, Research Division Alexia Dogani - JPMorgan Chase & Co, Research Division Tianyu Fu - Citigroup Inc., Research Division Presentation Operator Thank you for standing by.

New York, New York--(Newsfile Corp. - November 20, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Tandem Diabetes Care securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Bath & Body Works' stock suffers historic plunge after a disappointing earnings report, with the new CEO outlining a series of missteps.

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming January 12, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of Primo Brands Corporation (“Primo Brands” or the “Company”) (NYSE: PRMB) investors who purchased or otherwise acquired: (1) Primo Water Corporation (“Primo Water”) common stock between June 17, 2024 and November 8, 2024, inclusive; and/or (2) Primo Brands common stock between November 11, 2024 and November 6, 202.

Walmart is sliding into its Chilean shoppers' DMs—and it's working.

New York, New York--(Newsfile Corp. - November 20, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against CarMax, Inc. (NYSE: KMX) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in CarMax, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/carmax-inc-class-action-lawsuit.

New York, New York--(Newsfile Corp. - November 20, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against James Hardie Industries plc (NYSE: JHX) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in James Hardie, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/james-hardie-industries-class-action-lawsuit.

New York, New York--(Newsfile Corp. - November 20, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Synopsys, Inc. (NASDAQ: SNPS) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Synopsys, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/synopsys-inc-class-action-lawsuit.

New York, New York--(Newsfile Corp. - November 20, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Ardent Health, Inc. (NYSE: ARDT) for potential violations of the federal securities laws. If you invested in Ardent, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-health-inc-class-action-investigation.

New York, New York--(Newsfile Corp. - November 20, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Freeport-McMoRan Inc. (NYSE: FCX) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws. If you invested in Freeport, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/freeport-mcmoran-inc-class-action-lawsuit.

New York, New York--(Newsfile Corp. - November 20, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Inspire, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/inspire-medical-systems-inc-class-action-lawsuit.

New York, New York--(Newsfile Corp. - November 20, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Stride, Inc. (NYSE: LRN) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws. If you invested in Stride, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/stride-inc-class-action-lawsuit.